文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

不同类型损伤后第一周急性肾损伤危重患者的免疫特征分析:REALAKI研究

Immune profiling of critically ill patients with acute kidney injury during the first week after various types of injuries: the REALAKI study.
PubMed 文献 · Crit Care · 2024-07-08
一句话结论危重患者伤后早期急性肾损伤与初始炎症反应相关,第一周末仍存在急性肾损伤则与损伤诱导的免疫抑制相关。

REALAKI是REALISM队列的辅助分析,纳入3个ICU的359例危重患者(排除终末期肾病患者),在入ICU后第1–2天、第3–4天、第5–7天三次采集临床样本与数据,比较有无急性肾损伤患者的免疫特征。139例(39%)在第1–2天存在急性肾损伤,61例(20%)在第5–7天存在急性肾损伤,其中94%为持续性急性肾损伤。急性肾损伤患者促炎与抗炎细胞因子升高、固有免疫与适应性免疫应答改变,且随KDIGO分期升高改变趋于更明显。多因素logistic回归显示第1–2天急性肾损伤与CD10lowCD16low未成熟中性粒细胞相关(OR 3.03 [1.7-5.5],p<0.001),第5–7天急性肾损伤与IL-10升高(OR 1.38 [1.12-1.71],p=0.001)及LPS刺激后离体TNF-α产生减少(OR 0.51 [0.27-0.91],p=0.03)相关。

要点

  • 359例危重患者中139例(39%)在入ICU第1–2天存在急性肾损伤,61例(20%)在第5–7天存在急性肾损伤,其中94%为持续性急性肾损伤。
  • 第1–2天急性肾损伤与CD10lowCD16low未成熟中性粒细胞独立相关(OR 3.03 [1.7-5.5],p<0.001)。
  • 第5–7天急性肾损伤与IL-10升高(OR 1.38 [1.12-1.71],p=0.001)及LPS刺激后离体TNF-α产生减少(OR 0.51 [0.27-0.91],p=0.03)独立相关。
  • 急性肾损伤患者促炎与抗炎细胞因子升高、固有与适应性免疫应答改变,且随KDIGO分期升高改变趋于更明显。
  • 第1–2天至第5–7天急性肾损伤恢复者较持续性急性肾损伤者,这些免疫改变趋于纠正。

适用人群与场景

  • REALISM队列中3个ICU收治的359例危重患者,损伤类型包括创伤137例(38%)、术后103例(29%)、脓毒症95例(26%)、烧伤24例(7%)。
  • 排除终末期肾病患者。

诊断标准与关键阈值

  • 持续性急性肾损伤定义为第1–2天和第5–7天均存在急性肾损伤。
  • 急性肾损伤按KDIGO分期评估,免疫特征改变随KDIGO分期升高趋于更明显。

研究设计与关键结果

  • REALAKI为REALISM队列的辅助分析,纳入3个ICU的359例危重患者,排除终末期肾病患者,于入ICU后第1–2天、第3–4天、第5–7天三次采集临床样本与数据。
  • 139例(39%)在第1–2天存在急性肾损伤,61例(20%)在第5–7天存在急性肾损伤,第5–7天急性肾损伤患者中94%为持续性急性肾损伤。
  • 急性肾损伤患者促炎与抗炎细胞因子升高、固有免疫与适应性免疫应答改变,且随KDIGO分期升高改变趋于更明显。
  • 多因素logistic回归:第1–2天急性肾损伤与CD10lowCD16low未成熟中性粒细胞相关(OR 3.03 [1.7-5.5],p<0.001)。
  • 第5–7天急性肾损伤与IL-10升高(OR 1.38 [1.12-1.71],p=0.001)及LPS刺激后离体TNF-α产生减少(OR 0.51 [0.27-0.91],p=0.03)相关。
  • 第1–2天至第5–7天急性肾损伤恢复者较持续性急性肾损伤者,这些免疫改变趋于纠正。

证据类型、等级与局限

  • 证据类型:REALISM队列的辅助分析(观察性队列研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,不同类型严重损伤后早期急性肾损伤与初始炎症反应相关,伤后第一周末仍存在急性肾损伤与损伤诱导的免疫抑制相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Acute kidney injury (AKI) is common in hospitalized patients and results in significant morbidity and mortality. The objective of the study was to explore the systemic immune response of intensive care unit patients presenting with AKI, especially the association between immune profiles and persistent AKI during the first week after admission following various types of injuries (sepsis, trauma, surgery, and burns).

METHODS: REALAKI is an ancillary analysis of the REAnimation Low Immune Status Marker (REALISM) cohort study, in which 359 critically ill patients were enrolled in three different intensive care units. Patients with end-stage renal disease were excluded from the REALAKI study. Clinical samples and data were collected three times after admission: at day 1 or 2 (D1-2), day 3 or 4 (D3-4) and day 5, 6 or 7 (D5-7). Immune profiles were compared between patients presenting with or without AKI. Patients with AKI at both D1-2 and D5-7 were defined as persistent AKI. A multivariable logistic regression model was performed to determine the independent association between AKI and patients' immunological parameters.

RESULTS: Three hundred and fifty-nine patients were included in this analysis. Among them, 137 (38%) were trauma patients, 103 (29%) post-surgery patients, 95 (26%) sepsis patients, and 24 (7%) were burn patients. One hundred and thirty-nine (39%) patients presented with AKI at D1-2 and 61 (20%) at D5-7. Overall, 94% presented with persistent AKI at D5-7. Patients with AKI presented with increased pro and anti-inflammatory cytokines and altered innate and adaptive immune responses. The modifications observed in the immune profiles tended to be more pronounced with increasing KDIGO stages. In the logistic regression model, a statistically significant association was observed at D1-2 between AKI and CD10lowCD16low immature neutrophils (OR 3.03 [1.7-5.5]-p < 0.001). At D5-7, increased interleukin-10 (IL-10) levels and reduced ex vivo TNF-α production after LPS stimulation were significantly associated with the presence of AKI (OR 1.38 [1.12-1.71]-p = 0.001 and 0.51 [0.27-0.91]-p = 0.03, respectively). Patients who recovered from AKI between D1-2 and D5-7 compared to patients with persistent AKI at D5-7, tended to correct these alterations.

CONCLUSION: Following various types of severe injuries, early AKI is associated with the initial inflammatory response. Presence of AKI at the end of the first week after injury is associated with injury-induced immunosuppression.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Bidar F, Peillon L, Bodinier M, et al. Immune profiling of critically ill patients with acute kidney injury during the first week after various types of injuries: the REALAKI study. Crit Care. 2024. PMID: 38978044. doi:10.1186/s13054-024-04998-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。